The use of anti-psychotic and other psychotropic medication in a specialist community service for adults with learning disabilities

Author:

Clare Isabel C.H.,Wade Kelly A.,Bolton Sorcha,Wagner Adam P.,Steven Tatsiana,Holland Anthony J.

Abstract

Purpose The purpose of this paper is to examine the extent to which, in the five integrated community teams for adults with learning disabilities (CTLDs) in an English county-wide service, the use of psychotropic medication for service users was based on the presence of an appropriate mental health condition or epilepsy. Design/methodology/approach Adult participants were recruited following referral to one of the CTLDs for assessment, treatment and/or support of a possible mental health and/or behavioural need. Data were collected about participant characteristics and psychotropic medication 12 months after recruitment. Findings While a total of 42 (78 per cent) of the 54 participants were apparently prescribed regular or PRN (as required) psychotropic medication, only 24 (57 per cent) of these individuals had a recorded past or current mental health condition or epilepsy for which such medicine could be appropriate. Research limitations/implications There were several limitations: the sample size was small and its representativeness was uncertain; and data collection was compromised by barriers to explicit knowledge exchange within and across the learning disability service. Practical implications While recent guidance about the use of psychotropic medication is welcome, minimising inappropriate use requires more comprehensive person-centred interventions (including crisis management plans), underpinned by imaginative, but feasible, data collection methods and integrated formulations. Investment is needed in developments that support multi-disciplinary and inter-agency working to promote “good practice” by CTLDs in responding to referrals for possible mental health and/or behavioural needs. Originality/value Complementing recent large studies of primary care (General Practitioner) records, this is the first examination of the use of psychotropic medication by service users in English CTLDs.

Publisher

Emerald

Subject

Psychiatry and Mental health,Clinical Psychology,Developmental and Educational Psychology,Social Psychology,Pshychiatric Mental Health

Reference25 articles.

1. Beecham, J. and Knapp, M. (2001), “Costing psychiatric interventions”, in Thornicroft, G., Brewin, C. and Wing, J.K. (Eds), Measuring Mental Health Needs, Gaskell, London, pp. 1-22.

2. Joint Formulary Body (2016), British National Formulary (BNF), Pharmaceutical Press, London, available at: www.bnf.org/products/bnf-online (accessed 20 December 2016).

3. A systematic review of the prevalence of psychiatric disorders in adults with intellectual disability, 2003-2010;Journal of Mental Health Research in Intellectual Disabilities,2013

4. ‘What vision?’: experiences of team members in a community service for adults with intellectual disabilities;Journal of Intellectual Disability Research,2016

5. Use of antipsychotic drugs in individuals with intellectual disability (ID) in the Netherlands: prevalence and reasons for prescription;Journal of Intellectual Disability Research,2010

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3